EUVIMEDΑνακαλύψτε το EUVIMED
Crossref

Taraxerone exerts antipulmonary fibrosis effect through Smad signaling pathway and antioxidant stress response in a Sirtuin1 ‐dependent manner

Ziwei Chen, Weixi Xie, Siyuan Tang, Miao Lin, Lu Ren, Xiaoting Huang, Lang Deng, Rui Qian, Zun Wang, Dayang Xiong, Pingli Xie, Wei Liu iD

Phytotherapy Research · 2024

DOI: 10.1002/ptr.8221 ↗

At a glance

Journal article in Phytotherapy Research, 2024. Written by Ziwei Chen and 11 co-authors. Institution: Xiangya Nursing School, Central South University, Changsha, China. Major MEDLINE topics: Sirtuin 1, Pulmonary Fibrosis, Signal Transduction, Oxidative Stress. Cited 5 times so far (Crossref); 59 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, China, the Fund for the State Key Laboratory of Hunan Province, China.

ΠερίληψηSubjectsΒιβλιογραφικά στοιχείαCiteRelated studies

Abstract (original language)

Idiopathic pulmonary fibrosis treatments are limited, often with severe side effects, highlighting the need for novel options. Taraxerone has diverse biomedical properties, but its mechanism remains unclear. This study investigates taraxerone's impact and the mechanisms involved in bleomycin‐induced pulmonary fibrosis in mice. After establishing a pulmonary fibrosis mouse model, taraxerone was intraperitoneally injected continuously for 14–28 days. The in vivo antifibrotic and antioxidative stress effects of taraxerone were assessed. In vitro, the influence of taraxerone on transforming growth factor‐β1‐induced myofibroblast transformation and oxidative stress was investigated. Subsequently, quantitative polymerase chain reaction screened the histone deacetylase and Sirtuin family, and taraxerone's effects on SIRT1 were assessed. After SIRT1 siRNA treatment, changes in myofibroblast transformation and antioxidant capacity in response to taraxerone were observed. Acetylation and phosphorylation levels of Smad3 were evaluated. We also examined the binding levels of SIRT1 with Pho‐Smad3 and Smad3, as well as the nuclear localization of Smad2/3. EX527 confirmed SIRT1's in vivo action in response to taraxerone. In vitro experiments suggested that taraxerone inhibited myofibroblast differentiation by activating SIRT1 and reducing oxidative stress. We also observed a new interaction between SIRT1 and the Smad complex. Taraxerone activates SIRT1, enabling it to bind directly to Smad3. This leads to reduced Smad complex phosphorylation and limited nuclear translocation. As a result, the transcription of fibrotic factors is reduced. In vivo validation confirms taraxerone's SIRT1‐mediated antifibrotic effectiveness. This suggests that targeting SIRT1‐mediated inhibition of myofibroblast differentiation could be a key strategy in taraxerone‐based therapy for pulmonary fibrosis.

Subjects

MeSH terms (MEDLINE)

Sirtuin 1Pulmonary FibrosisSignal TransductionOxidative StressBleomycinSmad3 ProteinAntioxidantsMice, Inbred C57BLTransforming Growth Factor beta1AnimalsMiceMaleMyofibroblastsDisease Models, AnimalPhosphorylationAcetylation

Author keywords

SIRT1myofibroblast differentiationoxidative stresspulmonary fibrosistaraxerone

Substances

Sirtuin 1BleomycinSmad3 ProteinSirt1 protein, mouseAntioxidantsTransforming Growth Factor beta1Smad3 protein, mouse

Authors and institutions

  • Xiangya Nursing School, Central South University, Changsha, China.
  • Laboratory Medicine Department, Xiangya Hospital, Central South University, Changsha, China.
  • Clinical Nursing Teaching and Research Section, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Department of Dermatology, The Second Xiangya Hospital, Central South University, Changsha, China.
  • National Experimental Teaching Demonstration Center for Medical Function, Central South University, Changsha, China.

ORCID profiles: Wei Liu

Funding

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province, China
  • the Fund for the State Key Laboratory of Hunan Province, China
  • The open Sharing Fund for the Large-scale Instruments and Equipments of Central South University
  • The Science and Technology Innovation Program of Hunan province
  • the Fundamental Research Funds for the Central Universities of Central South University
  • Natural Science Foundation of Hunan Province
  • Fundamental Research Funds for Central Universities of the Central South University

Cite

APA

Chen, Z., Xie, W., Tang, S., Lin, M., Ren, L., Huang, X., Deng, L., Qian, R., Wang, Z., Xiong, D., Xie, P., & Liu, W. (2024). Taraxerone exerts antipulmonary fibrosis effect through Smad signaling pathway and antioxidant stress response in a Sirtuin1 ‐dependent manner. Phytotherapy Research. https://doi.org/10.1002/ptr.8221

Vancouver

Chen Z, Xie W, Tang S, Lin M, Ren L, Huang X, et al. Taraxerone exerts antipulmonary fibrosis effect through Smad signaling pathway and antioxidant stress response in a Sirtuin1 ‐dependent manner. Phytotherapy Research. 2024. doi:10.1002/ptr.8221

BibTeX
@article{Chen2024,
  author = {Chen, Ziwei and Xie, Weixi and Tang, Siyuan and Lin, Miao and Ren, Lu and Huang, Xiaoting and Deng, Lang and Qian, Rui and Wang, Zun and Xiong, Dayang and Xie, Pingli and Liu, Wei},
  title = {Taraxerone exerts antipulmonary fibrosis effect through Smad signaling pathway and antioxidant stress response in a Sirtuin1 ‐dependent manner},
  journal = {Phytotherapy Research},
  year = {2024},
  doi = {10.1002/ptr.8221}
}
Start for free →